BA
Brindaben Ankur Mehta
About Brindaben Ankur Mehta
Data last updated:
Brindaben Ankur Mehta is a Designated Partner at Klnext Enterprise Llp (since 2024). The companies operate in BFSI and Pharma. Earlier, Brindaben Ankur Mehta was a Director at Corona Remedies Limited (2004–2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 10 Oct 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Aug 2004 | 2004 | ₹1,202 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Brindaben Ankur Mehta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankur Kirtikumar Mehta | 00385547 | Klnext Enterprise Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Brindaben Ankur Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brindaben Ankur Mehta
Brindaben Ankur Mehta currently holds 1 directorship: Klnext Enterprise Llp (Designated Partner, since 10 Oct 2024).
Brindaben Ankur Mehta was first appointed on 27 Aug 2004 as Director at Corona Remedies Limited. The most recent appointment on record is 10 Oct 2024 at Klnext Enterprise Llp.
Brindaben Ankur Mehta held 1 earlier board appointment: Corona Remedies Limited (Director, 27 Aug 2004 to 01 Jan 2009).
The current boards of Brindaben Ankur Mehta's companies include Ankur Kirtikumar Mehta (Klnext Enterprise Llp).